መነሻ › ሙያዎች › Sales Representatives, Wholesale and Manufacturing, Technical and Scientific Products
Sales Representatives, Wholesale and Manufacturing, Technical and Scientific Products፡ የH-1B ደመወዞች
መደበኛ የሥራ ዘር ምድብ 41-4011። 668 የሥራ ሁኔታ ማመልከቻዎች፤ መካከለኛ የቀረበ መሠረታዊ ደመወዝ $96,650፣ መካከለኛ ግማሽ $76,950–$120,503።
ማመልከቻዎች (LCAs)668
መካከለኛ የሚቀርብ ደመወዝ$96,650
የደመወዞች መካከለኛ ግማሽ$76,950–$120,503
ከ10ኛ እስከ 90ኛ ፐርሰንታይል$64,275–$151,677
በደመወዝ ደረጃ
| የደመወዝ ደረጃ | LCAs | መካከለኛ ደመወዝ |
|---|---|---|
| ደረጃ I (መግቢያ) | 195 | $74,419 |
| ደረጃ II (ብቁ) | 206 | $97,306 |
| ደረጃ III (ልምድ ያለው) | 90 | $123,828 |
| ደረጃ IV (ሙሉ ብቃት ያለው) | 81 | $154,777 |
የሥራ ሚኒስቴር ለእያንዳንዱ ሙያ እና አካባቢ ከደረጃ I (መግቢያ) እስከ ደረጃ IV (ሙሉ በሙሉ ብቁ) ድረስ አራት የሚገባ ደመወዝ ደረጃዎችን ይወስናል። አሠሳሪው ከሥራው መስፈርቶች ጋር የሚስማማውን ደረጃ ይመርጣል።
አሠሪዎች
ከተሞች
የሥራ መደቦች
- Account Executive34
- Account Manager20
- Sales Representative17
- Sales Development Representative11
- Business Development Representative9
- Sales Account Manager8
- Business Development Manager8
- Business Development/Sales Associate of Biology Products8
- Enterprise Account Executive7
- IT Consultant (Technical Product Manager)7
- Product Manager6
- Sales Engineer6
- Global Account Manager5
- Inside Sales Representative5
- Key Account Sales Representative5
- Customer Success Manager5
- Sales Manager5
- Named Account Executive5
- Technical Sales Representative5
- Account Manager II5
- Territory Manager4
- Business Development Director4
- Territory Account Executive4
- Surgical Device Sales Representative4
- Senior Account Executive4
- Clinical Specialist Latin America4
- Regional Marketing Specialist4
- Key Account Manager4
- Sales Executive4
- Clinical Specialist4
በፊስካል ዓመት
| የፋይናንስ ዓመት | LCAs | መካከለኛ ደመወዝ |
|---|---|---|
| FY2023 | 140 | $93,142 |
| FY2024 | 160 | $86,658 |
| FY2025 | 197 | $95,000 |
| FY2026 | 171 | $110,000 |
ደመወዞች በእያንዳንዱ ማመልከቻ ላይ በተገለጸው ደመወዝ ዝቅተኛ ጫፍ ሲሆኑ ወደ ዓመታዊ መጠን ተቀይረዋል፤ ስታቲስቲክሶች የተረጋገጡ ሙሉ ጊዜ ማመልከቻዎችን ብቻ ይጠቀማሉ። LCA የቪዛ ማረጋገጫ አይደለም፤ አንድ LCA ለብዙ ቦታዎች ሊሸፍን ይችላል። ምንጭ፡ የአሜሪካ የሥራ ሚኒስቴር፣ OFLC LCA መረጃ ማሳያ መረጃ፣ የፋይናንስ ዓመታት 2023–2026 (የቅርብ ጊዜ ውሳኔ 30 ጁን 2026)።